# Agomelatine

## Valdoxan 25mg

| 藥物代碼           | OVALD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of major depression in adults                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 副作用             | Nervous system: Headache (14.1%), Dizziness (5.5%), Somnolence (2.9%), Migraine(1.2%), Tremor (1%), paraesthesia (0.9%)Gastrointestinal: Nausea (7.7%), Dry mouth (3.5%), Diarrhea (3.1%), Abdominal pain upper (2.4%), Constipation (1.8%), Dyspepsia (1.3%)Infections and infestations: Influenza (2.3%), Nasopharyngitis (2.1%)Psychiatric: Insomnia (2.4%), Anxiety (2%), Depression (1.3%)General: Fatigue (2.6%)Skin and subcutaneous tissue: Hyperhidrosis (1.3%),  eczema (0.2%), erythematous rash (0.1%)Musculoskeletal and connective tissue: Back pain (1.5%)Ear and labyrinth: Vertigo (1.1%)Eye disorders: blurred vision (0.6%).Hepato-biliary disorders: increases (>3 times the upper limit of the normal range) in ALT and/or AST (1.1%), hepatitis (0.03%) |
| 禁忌               | 1. Patients with a history of previous hypersensitivity to the active ingredient or any of the excipients 2.Patients with hepatic impairment (i.e. cirrhosis or active liver disease) 3. Taking potent CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | The recommended daily dose: 25mg PO HS. After two weeks of treatment, if there is no improvement in symptoms, the dose may be increased to 50mg once daily, taken as a single dose at bedtime. The maximum recommended dose should not be exceeded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 肝功能異常         | 無需調整劑量  肝功能不全者如:cirrhosis, active liver disease, or transaminases exceeding 3 times ULN)不建議使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 附帶說明           | It is not known whether agomelatine is excreted into human milk. Agomelatine and/or its metabolites were excreted in the milk of lactating rats. There were no adverse effects on offspring following oral administration of agomelatine to rats from prior to mating until weaning, with systemic exposures (plasma AUC) of 100-fold human exposure at the maximal recommended clinical dose.The effects of agomelatine on the nursing infant have not been established. If treatment with agomelatine is considered necessary, breastfeeding should be discontinued.                                                                                                                                                                                                        |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

